Boston Partners’s VivoSim Labs VIVS Stock Holding History

Boston Partners’s Portfolio VIVS Stock Details VIVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-281	Closed	-$515K	–	750
2014 Q1	$515K	Buy	+281	New	+$653K	﹤0.01%	688

Other funds holding VIVS

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

UBS Zurich, Switzerland $136B AUM 16.36% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

CNB

City National Bank Beverly Hills, Delaware $11.6B AUM 3.11% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $15.9B AUM 53.4% 1-Year Est. Return

Boston Partners's VIVS Position: Q2 2014 in Review

Boston Partners sold out of VivoSim Labs (VIVS) in Q2 2014, closing a stake of 281 shares — an estimated $515K sold.

Boston Partners first reported a position in VIVS in Q1 2014 and held it in 1 quarter. The position peaked at $515K in Q1 2014. 115 funds tracked by Wall St. Rank hold VIVS as of Q2 2014.

Boston Partners reported no remaining VivoSim Labs position as of Q2 2014 after selling out during the quarter.
Boston Partners sold 281 VivoSim Labs shares in Q2 2014, an estimated $515K.
Boston Partners first reported a position in VivoSim Labs in Q1 2014 and held it in 1 quarter.
Boston Partners's VivoSim Labs position peaked at $515K in Q1 2014.
115 funds tracked by Wall St. Rank held VivoSim Labs as of Q2 2014.

Based on Boston Partners's 13F filing for Q2 2014, filed 8 Aug 2014.